PUBLIC CONTRACT · 2017
AQ100357 aquisição de medicamentos tratamento hepatite sofosbuvir+ledipasvir 2017
- Contract value
- €816,251.94
- Signed on
- 1 February 2017
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3583752PUBLISHED SUBJECT
AQ100357 AQUISIÇÃO DE MEDICAMENTOS TRATAMENTO HEPATITE SOFOSBUVIR+LEDIPASVIR 2017
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES, LDA · Tax ID 503604704
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €816,251.94
- Procedure base price
- €816,251.94
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 August 2017
- Award date
- 1 February 2017
- Signing date
- 1 February 2017
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33620000-2 - Medicamentos para o sangue, para os órgãos hematopoiéticos e para o aparelho cardiovascular
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2869218
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.